Natera Total Liabilities and Share Holders Equity 2014-2024 | NTRA

Natera total liabilities and share holders equity from 2014 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Natera total liabilities and share holders equity for the quarter ending June 30, 2024 was $1.517B, a 21.56% increase year-over-year.
  • Natera total liabilities and share holders equity for 2023 was $1.442B, a 3.39% increase from 2022.
  • Natera total liabilities and share holders equity for 2022 was $1.394B, a 12.78% increase from 2021.
  • Natera total liabilities and share holders equity for 2021 was $1.236B, a 32.65% increase from 2020.
Natera Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,442
2022 $1,394
2021 $1,236
2020 $932
2019 $583
2018 $268
2017 $215
2016 $211
2015 $265
2014 $124
2013 $60
Natera Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,517
2024-03-31 $1,468
2023-12-31 $1,442
2023-09-30 $1,447
2023-06-30 $1,248
2023-03-31 $1,319
2022-12-31 $1,394
2022-09-30 $1,009
2022-06-30 $1,067
2022-03-31 $1,145
2021-12-31 $1,236
2021-09-30 $1,311
2021-06-30 $850
2021-03-31 $894
2020-12-31 $932
2020-09-30 $977
2020-06-30 $723
2020-03-31 $559
2019-12-31 $583
2019-09-30 $380
2019-06-30 $383
2019-03-31 $261
2018-12-31 $268
2018-09-30 $277
2018-06-30 $194
2018-03-31 $219
2017-12-31 $215
2017-09-30 $204
2017-06-30 $158
2017-03-31 $176
2016-12-31 $211
2016-09-30 $242
2016-06-30 $261
2016-03-31 $266
2015-12-31 $265
2015-09-30 $262
2015-06-30 $107
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $60
Sector Industry Market Cap Revenue
Medical Medical Services $16.570B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00